U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula 3Cl.Fe.6H2O
Molecular Weight 270.296
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of FERRIC CHLORIDE HEXAHYDRATE

SMILES

O.O.O.O.O.O.[Cl-].[Cl-].[Cl-].[Fe+3]

InChI

InChIKey=NQXWGWZJXJUMQB-UHFFFAOYSA-K
InChI=1S/3ClH.Fe.6H2O/h3*1H;;6*1H2/q;;;+3;;;;;;/p-3

HIDE SMILES / InChI

Description
Sources: http://www.mfc.co.jp/english/eng/product/sanferol/pdf/fls_gras_notice.pdfhttps://mistralhowto.wordpress.com/2012/03/12/what-is-pigment-yellow-42-and-what-is-it-used-for/ | http://sensientfoodcolors.com/en-us/confection/iron-oxides-approved-by-the-fda/ | https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm?fr=73.2250 | https://www.drugs.com/inactive/ferric-oxide-yellow-381.htmlhttps://books.google.ru/books?id=vxtxWneRBN4C&pg=PA1103&#v=onepage&q&f=falsehttps://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/205874Orig1s000PharmR.pdfhttp://www.edta-chelate.com/ferric-ammonium-edta-liquid--1640836.htmlhttps://books.google.ru/books?id=3hLmyma2-MsC&pg=PA241&lpg=PA241&dq=FERRIC+AMMONIUM+CHLORIDE retrieved from A Consumer's Dictionary of Cosmetic Ingredients, 7th Edition: Complete Information About the Harmful and Desirable Ingredients Found in Cosmetics and Cosmeceuticals By Ruth Winterhttps://www.ncbi.nlm.nih.gov/pubmed/27995746 | http://onlinelibrary.wiley.com/doi/10.1002/047084289X.rn01568/abstract?userIsAuthenticated=false&deniedAccessCustomisedMessage=https://cameochemicals.noaa.gov/chemical/3468 | https://www.ncbi.nlm.nih.gov/pubmed/2135524https://www.ncbi.nlm.nih.gov/pubmed/27684194 | https://www.ncbi.nlm.nih.gov/pubmed/17511797 | https://www.ncbi.nlm.nih.gov/pubmed/1427505
Curator's Comment: description was created based on several sources, including https://www.gpo.gov/fdsys/pkg/CFR-1996-title21-vol3/pdf/CFR-1996-title21-vol3-sec182-5375.pdf

Ferric chloride is a compound used as a food additive, a haemostatic or treatment for hypochromic anaemia. Ferric chloride induced vascular injury is a widely used model of occlusive thrombosis that reports platelet activation and aggregation in the context of an aseptic closed vascular system. Iron i.v. ferric chloride (960 mg) has being shown to be effective in correcting anaemia in HD patients with iron deficiency.

Originator

Monsanto Chemicals
44
Curator's Comment: The relation between phosphate level and ferric citrate consumption was first discovered in 1940s.

Approval Year

1921
1467
Targets

Targets

Primary TargetPharmacologyConditionPotency
Activator
1430
Chelating Agent
142
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Approved
8429
Additrace N

Approved Use

A source of electrolytes and trace elements as an integral part of a complete intravenous nutritional regimen, for adults and children over 40 kg.
Preventing
Approved
8429
Parmirin

Approved Use

Preventive treatment of iron deficiency
Primary
Basic research
Unknown

Approved Use

Unknown
Primary
Approved
8429
SANFEROL

Approved Use

It has also been reported that SFC preparation improved iron deficiency in a pregnant woman with iron deficiency anemia whose hemoglobin level had not increased after administration of other iron preparations such as ferrous fumarate. A dairy supplemental dose of SFC improved iron deficiency in young women with iron deficiency.
Inactive ingredient
Approved
8429
Oxycontin

Approved Use

OxyContin is used in the treatment of chronic pain; pain and belongs to the drug class narcotic analgesics.

Launch Date

1998
Curative
Approved
8429
RADIOGARDASE

Approved Use

Insoluble Prussian blue is indicated for treatment of patients with known or suspected internal contamination with radioactive cesium and/or radioactive or non-radioactive thallium to increase their rates of elimination.

Launch Date

2003
Palliative
Approved
8429
AURYXIA

Approved Use

Ferric Citrate is a phosphate binder indicated for the control of serum phosphorus levels in patients with chronic kidney disease on dialysis.

Launch Date

2014
PubMed

PubMed

TitleDatePubMed
The formation of ferritin from apoferritin. Catalytic action of apoferritin.
1973 Oct
Contact dermatitis to yellow iron oxide.
1985 Aug
Effect of physical exercise and vitamin C on absorption of ferric sodium citrate.
1996 Dec
Non-invasive and non-destructive micro-XRF and micro-Raman analysis of a decorative wallpaper from the beginning of the 19th century.
2007 Feb
Interaction of omapatrilat with FD&C Blue No. 2 lake during dissolution of modified release tablets.
2007 Jul 18
Fabrication of FeF3 Nanoflowers on CNT branches and their application to high power lithium rechargeable batteries.
2010 Dec 7
Thermal behavior study and decomposition kinetics of amiodarone hydrochloride under isothermal conditions.
2011 Jun
Finnish wallpaper pigments in the 18th-19th century: presence of KFe3(CrO4)2(OH)6 and odd pigment mixtures.
2013 Apr
Microwave assisted convenient one-pot synthesis of coumarin derivatives via Pechmann condensation catalyzed by FeF3 under solvent-free conditions and antimicrobial activities of the products.
2014 Aug 26
Heme Binding by Corynebacterium diphtheriae HmuT: Function and Heme Environment.
2015 Nov 3
Superior electrochemical performance of N-doped nanocrystalline FeF(3)/C with a single-step solid-state process.
2016 Oct 4
Phosphorus recovery from biogas slurry by ultrasound/H(2)O(2) digestion coupled with HFO/biochar adsorption process.
2017 Feb
Effect of iron and carbon monoxide on fibrinogenase-like degradation of plasmatic coagulation by venoms of four Crotalus species.
2017 Jan
Patents

Patents

20080188032
44
20090216060
44
6258758
44
US 5206265 A
44
US2385188
44
US3873678
44
US4364871
44
US6881255
44
US6903235
44
US7198668
44
US8071067
44

Sample Use Guides

In Vivo Use Guide
Curator's Comment: Iron oxides black, red and yellow are intended to be used as colourants in feedingstuffs for all animal species without dose or age restriction. The applicant recommends 500–1,200 mg/kg of the additives in complete (and complementary) feedingstuffs as standard dose. http://onlinelibrary.wiley.com/doi/10.2903/j.efsa.2016.4482/full
Ferric sodium citrate is an additive used in various foods such as baby milk powder, school and hospital food, beverages, cereals and supplements. It is administered orally.
Route of Administration: Oral
In Vitro Use Guide
Unknown
Name Type Language
FERRIC CHLORIDE HEXAHYDRATE
EP   MI   WHO-DD  
Common Name English
IRON(3+) CHLORIDE HEXAHYDRATE
Systematic Name English
IRON CHLORIDE (FECL3.6H2O)
Common Name English
FERRIC CHLORIDE HEXAHYDRATE [EP MONOGRAPH]
Common Name English
FERRIC CHLORIDE HEXAHYDRATE [MI]
Common Name English
FERRIC TRICHLORIDE HEXAHYDRATE
Common Name English
FERRUM MURIATICUM [HPUS]
Common Name English
IRON(III) CHLORIDE HEXAHYDRATE
Systematic Name English
FERRUM MURIATICUM
HPUS  
Common Name English
Ferric chloride hexahydrate [WHO-DD]
Common Name English
IRON PERCHLORIDE, HEXAHYDRATE
Common Name English
Code System Code Type Description
MERCK INDEX
m5316
Created by admin on Fri Dec 15 17:24:52 GMT 2023 , Edited by admin on Fri Dec 15 17:24:52 GMT 2023
PRIMARY Merck Index
EPA CompTox
DTXSID30894792
Created by admin on Fri Dec 15 17:24:52 GMT 2023 , Edited by admin on Fri Dec 15 17:24:52 GMT 2023
PRIMARY
SMS_ID
100000078740
Created by admin on Fri Dec 15 17:24:52 GMT 2023 , Edited by admin on Fri Dec 15 17:24:52 GMT 2023
PRIMARY
MESH
C024555
Created by admin on Fri Dec 15 17:24:52 GMT 2023 , Edited by admin on Fri Dec 15 17:24:52 GMT 2023
PRIMARY
EVMPD
SUB13837MIG
Created by admin on Fri Dec 15 17:24:52 GMT 2023 , Edited by admin on Fri Dec 15 17:24:52 GMT 2023
PRIMARY
DAILYMED
0I2XIN602U
Created by admin on Fri Dec 15 17:24:52 GMT 2023 , Edited by admin on Fri Dec 15 17:24:52 GMT 2023
PRIMARY
RXCUI
1323279
Created by admin on Fri Dec 15 17:24:52 GMT 2023 , Edited by admin on Fri Dec 15 17:24:52 GMT 2023
PRIMARY RxNorm
PUBCHEM
24810
Created by admin on Fri Dec 15 17:24:52 GMT 2023 , Edited by admin on Fri Dec 15 17:24:52 GMT 2023
PRIMARY
CHEBI
86254
Created by admin on Fri Dec 15 17:24:52 GMT 2023 , Edited by admin on Fri Dec 15 17:24:52 GMT 2023
PRIMARY
FDA UNII
0I2XIN602U
Created by admin on Fri Dec 15 17:24:52 GMT 2023 , Edited by admin on Fri Dec 15 17:24:52 GMT 2023
PRIMARY
CAS
10025-77-1
Created by admin on Fri Dec 15 17:24:52 GMT 2023 , Edited by admin on Fri Dec 15 17:24:52 GMT 2023
PRIMARY
ACTIVE MOIETY
Structure of FERRIC CATION
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966